LifeStance Health Group/$LFST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LifeStance Health Group
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Ticker
$LFST
Sector
Primary listing
Employees
7,708
Headquarters
Website
LFST Metrics
BasicAdvanced
$1.9B
-
-$0.04
1.13
-
Price and volume
Market cap
$1.9B
Beta
1.13
52-week high
$8.30
52-week low
$3.74
Average daily volume
1.4M
Financial strength
Current ratio
1.481
Quick ratio
1.316
Long term debt to equity
28.244
Total debt to equity
32.176
Interest coverage (TTM)
0.12%
Profitability
EBITDA (TTM)
60.054
Gross margin (TTM)
32.52%
Net profit margin (TTM)
-1.23%
Operating margin (TTM)
0.19%
Effective tax rate (TTM)
25.47%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
0.04%
Return on equity (TTM)
-1.11%
Valuation
Price to revenue (TTM)
1.424
Price to book
1.29
Price to tangible book (TTM)
-562.25
Price to free cash flow (TTM)
15.619
Free cash flow yield (TTM)
6.40%
Free cash flow per share (TTM)
0.314
Growth
Revenue change (TTM)
13.86%
Earnings per share change (TTM)
-89.57%
3-year revenue growth (CAGR)
19.24%
3-year earnings per share growth (CAGR)
-65.53%
What the Analysts think about LFST
Analyst ratings (Buy, Hold, Sell) for LifeStance Health Group stock.
Bulls say / Bears say
LifeStance’s total revenue rose 11% year-over-year to $345.3 million in Q2 2025, driven by a $32.9 million increase in patient service revenue, highlighting strong demand for its outpatient mental health offerings. (SEC Q2 10-Q)
Adjusted EBITDA climbed 19% to $34.0 million in Q2 2025, indicating improved operational leverage as the scaling of outpatient care drives efficiencies. (SEC Q2 10-Q)
LifeStance added a net 748 clinicians year-over-year in Q2 2025, fueling a 12% increase in patient visits to 2.2 million and demonstrating the strength of its expansion and recruitment strategies. (SEC Q2 10-Q)
Despite higher patient volumes, LifeStance posted a GAAP net loss of $3.8 million in Q2 2025, showing the company remains unprofitable on a reported basis. (SEC Q2 10-Q)
Total revenue per visit declined year-over-year in Q2 2025 due to a reduction in reimbursement rates from a single payor. This partially offset the gains from higher patient volumes, revealing risks related to reliance on certain payors. (SEC Q2 10-Q)
After entering into a new credit agreement in December 2024, LifeStance had $288.2 million in term loan debt as of March 31, 2025, leaving it vulnerable to interest rate increases and refinancing risks in a rising rate environment. (SEC Q1 10-Q)
Data summarised monthly by Lightyear AI. Last updated on 2 Nov 2025.
LFST Financial Performance
Revenues and expenses
LFST Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LifeStance Health Group stock?
LifeStance Health Group (LFST) has a market cap of $1.9B as of November 02, 2025.
What is the P/E ratio for LifeStance Health Group stock?
The price to earnings (P/E) ratio for LifeStance Health Group (LFST) stock is 0 as of November 02, 2025.
Does LifeStance Health Group stock pay dividends?
No, LifeStance Health Group (LFST) stock does not pay dividends to its shareholders as of November 02, 2025.
When is the next LifeStance Health Group dividend payment date?
LifeStance Health Group (LFST) stock does not pay dividends to its shareholders.
What is the beta indicator for LifeStance Health Group?
LifeStance Health Group (LFST) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.